Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients

BACKGROUND: Colon adenocarcinoma (COAD) is a highly heterogeneous disease, thus making prognostic predictions uniquely challenging. Metabolic reprogramming is emerging as a novel cancer hallmark that may serve as the basis for more effective prognosis strategies. METHODS: The mRNA expression profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yang, Wu, Rilige, Wang, Ximo, Yin, Chengliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021388/
https://www.ncbi.nlm.nih.gov/pubmed/35462848
http://dx.doi.org/10.3389/fpubh.2022.860381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021388/
https://www.ncbi.nlm.nih.gov/pubmed/35462848
http://dx.doi.org/10.3389/fpubh.2022.860381

Ejemplares similares